47366 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 26
00:42 UTC
|
AMAT
Applied Materials
|
◎ Target | Vijay Rakesh ★★★☆☆ #2142 | Outperform | $650.00→ $590.00-9.2% |
|
Aug 26
00:42 UTC
|
ALB
Albemarle
|
◎ Target | Jeffrey Zekauskas ★★★☆☆ #1861 | Neutral | $160.00→ $140.00-12.5% |
|
Aug 26
00:42 UTC
|
ACN
Accenture
|
◎ Target | Darrin Peller ★★★☆☆ #1739 | Outperform | $165.00→ $215.00+30.3% |
|
Aug 26
00:42 UTC
|
ACM
AECOM
|
◎ Target | John Staszak ★★☆☆☆ #2655 | Buy | $85.00→ $75.00-11.8% |
|
Aug 26
00:42 UTC
|
ACAD
ACADIA Pharmaceuticals
|
◎ Target | David Hoang ★★☆☆☆ #2418 | Buy | $37.00→ $38.00+2.7% |
|
Aug 26
00:42 UTC
|
ACAD
ACADIA Pharmaceuticals
|
◎ Target | Jeffrey Hung not yet tracked | Equal Weight | $27.00→ $28.00+3.7% |
|
Aug 26
00:42 UTC
|
ACAD
ACADIA Pharmaceuticals
|
◎ Target | Yigal Nochomovitz ★★☆☆☆ #2797 | Buy | $39.00→ $40.00+2.6% |
|
Aug 26
00:42 UTC
|
ABX
Barrick Gold
|
◎ Target | firm only | Buy | C$68.00→ C$73.00+7.4% |
|
Aug 26
00:42 UTC
|
ABT
Abbott Laboratories
|
◎ Target | Joshua Jennings not yet tracked | Buy | $115.00→ $135.00+17.4% |
|
Aug 26
00:42 UTC
|
RLI
RLI
|
↓ Downgrade | Andrew Andersen ★★★☆☆ #1996 | Hold→ Underperform | $53.00 |
|
Aug 26
00:42 UTC
|
PAY
Paymentus
|
↓ Downgrade | Darrin Peller ★★★☆☆ #1739 | Outperform→ Peer Perform | |
|
Aug 26
00:42 UTC
|
FIVE
Five Below
|
↓ Downgrade | Anthony Chukumba ★★☆☆☆ #2464 | Buy→ Hold | $250.00 |
|
Aug 26
00:42 UTC
|
ANAB
AnaptysBio
|
↓ Downgrade | firm only | Hold | $70.00 |
|
Aug 26
00:42 UTC
|
SMMT
Summit Therapeutics
|
↑ Upgrade | Jeffrey Walch not yet tracked | Underperform→ Market Perform | $9.80→ $11.90+21.4% |
|
Aug 26
00:42 UTC
|
MRNA
Moderna
|
↑ Upgrade | Alexandria Hammond ★★★☆☆ #1561 | Underperform→ Peer Perform | |
|
Aug 26
00:42 UTC
|
FOUR
Shift4 Payments
|
↑ Upgrade | Jason Kupferberg ★★★☆☆ #1056 | Equal Weight→ Overweight | $55.00→ $59.00+7.3% |
|
Aug 26
00:42 UTC
|
FLNC
Fluence Energy
|
↑ Upgrade | Jon Windham ★☆☆☆☆ #3050 | Sell→ Neutral | $9.00→ $12.00+33.3% |
|
Aug 26
00:42 UTC
|
DT
Dynatrace
|
↑ Upgrade | Sanjit Singh ★★★★☆ #489 | Equal Weight→ Overweight | $58.00→ $65.00+12.1% |
|
Aug 26
00:42 UTC
|
CAPR
Capricor Therapeutics
|
↑ Upgrade | firm only | Market Perform→ Outperform | |
|
Aug 26
00:42 UTC
|
BNS
Bank of Nova Scotia
|
↑ Upgrade | firm only | Hold→ Buy | |
|
Aug 26
00:42 UTC
|
BFH
Bread Financial
|
↑ Upgrade | Darrin Peller ★★★☆☆ #1739 | Peer Perform→ Outperform | $130.00 |
|
Aug 26
00:42 UTC
|
AMD
Advanced Micro Devices
|
↑ Upgrade | Simon Leopold ★★★★☆ #450 | Outperform→ Strong-Buy | $565.00→ $641.00+13.5% |
|
Aug 26
00:42 UTC
|
AFLYY
Air France-KLM
|
↑ Upgrade | firm only | Reduce→ Hold | |
|
Aug 25
21:42 UTC
|
REAX
Real Brokerage
|
◎ Target | Matthew Erdner ★★★☆☆ #1649 | Buy | $4.00→ $40.00+900.0% |
|
Aug 25
21:42 UTC
|
ABT
Abbott Laboratories
|
◎ Target | Joshua Jennings not yet tracked | Buy | $115.00→ $135.00+17.4% |
|
Aug 25
18:41 UTC
|
RDS
Radisson Mining Resources
|
◎ Target | firm only | Outperform | C$2.25→ C$2.45+8.9% |
|
Aug 25
18:41 UTC
|
LAR
Lithium Americas (Argentina)
|
◎ Target | firm only | Buy | $11.00→ $13.00+18.2% |
|
Aug 25
18:41 UTC
|
HR.UN
H&R Real Estate Investment Trust
|
◎ Target | firm only | Buy | C$11.50→ C$11.00-4.3% |
|
Aug 25
18:41 UTC
|
DNLI
Denali Therapeutics
|
◎ Target | Mayank Mamtani ★★☆☆☆ #2842 | Buy | $30.00→ $35.00+16.7% |
|
Aug 25
18:41 UTC
|
ACAD
ACADIA Pharmaceuticals
|
◎ Target | David Hoang ★★☆☆☆ #2418 | Buy | $37.00→ $38.00+2.7% |
|
Aug 25
18:41 UTC
|
ABX
Barrick Gold
|
◎ Target | firm only | Buy | C$68.00→ C$73.00+7.4% |
|
Aug 25
17:41 UTC
|
ULTA
Ulta Beauty
|
◎ Target | Krisztina Katai ★★★★☆ #886 | Buy | $692.00→ $695.00+0.4% |
|
Aug 25
17:41 UTC
|
OLN
Olin
|
◎ Target | David Begleiter ★★★☆☆ #2111 | Hold | $30.00→ $20.00-33.3% |
|
Aug 25
17:41 UTC
|
KWR
Quaker Houghton
|
◎ Target | David Begleiter ★★★☆☆ #2111 | Buy | $165.00→ $185.00+12.1% |
|
Aug 25
17:41 UTC
|
KRO
Kronos Worldwide
|
◎ Target | David Begleiter ★★★☆☆ #2111 | Buy | $6.00→ $9.00+50.0% |
|
Aug 25
17:41 UTC
|
CLMT
Calumet
|
◎ Target | Manav Gupta ★★★★☆ #396 | Neutral | $26.00→ $47.00+80.8% |
|
Aug 25
17:41 UTC
|
BNS
Bank of Nova Scotia
|
↑ Upgrade | firm only | Hold→ Buy | |
|
Aug 25
16:41 UTC
|
XYZ
Block
|
◎ Target | Darrin Peller ★★★☆☆ #1739 | Outperform | $100.00→ $115.00+15.0% |
|
Aug 25
16:41 UTC
|
NTNX
Nutanix
|
◎ Target | Radi Sultan ★★★★★ #97 | Buy | $62.00→ $80.00+29.0% |
|
Aug 25
16:41 UTC
|
M
Macy's
|
◎ Target | Paul Lejuez ★★★☆☆ #1282 | Neutral | $22.00→ $24.00+9.1% |
|
Aug 25
16:41 UTC
|
LULU
lululemon athletica
|
◎ Target | Jay Sole ★★★☆☆ #2172 | Neutral | $124.00→ $120.00-3.2% |
|
Aug 25
16:41 UTC
|
COTY
Coty
|
◎ Target | Dara Mohsenian ★★★★★ #220 | Equal Weight | $2.50→ $2.75+10.0% |
|
Aug 25
16:41 UTC
|
BXP
BXP
|
◎ Target | Michael Goldsmith ★★★☆☆ #1333 | Neutral | $61.00→ $70.00+14.8% |
|
Aug 25
16:41 UTC
|
ACAD
ACADIA Pharmaceuticals
|
◎ Target | Jeffrey Hung not yet tracked | Equal Weight | $27.00→ $28.00+3.7% |
|
Aug 25
15:41 UTC
|
SYF
Synchrony Financial
|
◎ Target | Darrin Peller ★★★☆☆ #1739 | Outperform | $85.00→ $90.00+5.9% |
|
Aug 25
15:41 UTC
|
SNOW
Snowflake
|
◎ Target | Yi Fu not yet tracked | Buy | $290.00→ $360.00+24.1% |
|
Aug 25
15:41 UTC
|
RGNX
REGENXBIO
|
◎ Target | Yi Chen ★★☆☆☆ #2512 | Buy | $23.00→ $21.00-8.7% |
|
Aug 25
15:41 UTC
|
RELY
Remitly Global
|
◎ Target | Darrin Peller ★★★☆☆ #1739 | Outperform | $31.00→ $32.00+3.2% |
|
Aug 25
15:41 UTC
|
PPL
PPL
|
◎ Target | Paul Zimbardo not yet tracked | Buy | $48.00→ $44.00-8.3% |
|
Aug 25
15:41 UTC
|
PAYP
PayPay
|
◎ Target | Darrin Peller ★★★☆☆ #1739 | Outperform | $18.00→ $21.00+16.7% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.